OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy
Valentina Condelli, Fabiana Crispo, Michele Pietrafesa, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 532-532
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
Sarah‐Maria Fendt, Christian Frezza, Ayelet Erez
Cancer Discovery (2020) Vol. 10, Iss. 12, pp. 1797-1807
Open Access | Times Cited: 215

Heat-shock proteins: chaperoning DNA repair
Laurence Dubrez, Sébastien Causse, Natália Borges Bonan, et al.
Oncogene (2019) Vol. 39, Iss. 3, pp. 516-529
Closed Access | Times Cited: 171

Old and New Approaches to Target the Hsp90 Chaperone
Jackee Sanchez, Trever R. Carter, Mark S. Cohen, et al.
Current Cancer Drug Targets (2019) Vol. 20, Iss. 4, pp. 253-270
Open Access | Times Cited: 156

HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
Zinan Li, Ying Luo
Oncology Reports (2022) Vol. 49, Iss. 1
Open Access | Times Cited: 107

Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond
Benjamin Lang, Martin E. Guerrero-Gimenez, Thomas L. Prince, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4507-4507
Open Access | Times Cited: 81

AhR and Cancer: From Gene Profiling to Targeted Therapy
Anaïs Paris, Nina Tardif, Marie‐Dominique Galibert, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 752-752
Open Access | Times Cited: 66

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma
Manfei Pi, Huixian Kuang, Chunyan Yue, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100822-100822
Closed Access | Times Cited: 58

Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis
Haizhou Liu, Zihan Zhang, Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 57

Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance
Jian Zhang, Houde Li, Yu Liu, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2778-2778
Open Access | Times Cited: 43

Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10

Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?
Pavel Burko, Giuseppa D’Amico, Ilia Miltykh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4883-4883
Open Access | Times Cited: 19

Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Fabiana Crispo, Valentina Condelli, Silvia Lepore, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 798-798
Open Access | Times Cited: 47

HSP90 and Co-chaperones: Impact on Tumor Progression and Prospects for Molecular-Targeted Cancer Therapy
Ameneh Jafari, Mostafa Rezaei‐Tavirani, Behrouz Farhadihosseinabadi, et al.
Cancer Investigation (2020) Vol. 38, Iss. 5, pp. 310-328
Closed Access | Times Cited: 41

Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins
Beatrice Parma, Heiko Wurdak, Paolo Ceppi
Drug Resistance Updates (2022) Vol. 65, pp. 100888-100888
Open Access | Times Cited: 27

Selection for robust metabolism in domesticated yeasts is driven by adaptation to Hsp90 stress
Natalia Condic, Hatim Amiji, Dipak R. Patel, et al.
Science (2024) Vol. 385, Iss. 6707
Closed Access | Times Cited: 5

High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer
Shuming Zhang, Shichao Guo, Zhangfu Li, et al.
PeerJ (2019) Vol. 7, pp. e7946-e7946
Open Access | Times Cited: 38

Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease
Linda Anna Michelle Kulka, Pia-Victoria Fangmann, Diana Panfilova, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 36

Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas
Shiyou Wei, Delong Yin, Shengnan Yu, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2180-2195
Open Access | Times Cited: 22

The roles of molecular chaperones in regulating cell metabolism
M. Binder, Anthony M. Pedley
FEBS Letters (2023) Vol. 597, Iss. 13, pp. 1681-1701
Open Access | Times Cited: 12

Yoga and its effect on sperm genomic integrity, gene expression, telomere length and perceived quality of life in early pregnancy loss
Vidhu Dhawan, Neena Malhotra, Neeta Singh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Perillaldehyde ameliorates sepsis-associated acute kidney injury via inhibiting HSP90AA1-mediated ferroptosis and pyroptosis: Molecular structure and protein interaction of HSP90AA1
Shuai Liu, Yunfei Xu, Xudong Yao, et al.
International Journal of Biological Macromolecules (2025) Vol. 304, pp. 140954-140954
Closed Access

Inhibition of the SERPINB5/HSP90AA1 axis restrains the proliferation and invasion of rectal cancer
Zixing Meng, Jili Hu, Hao Wu, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access

The Hsp90β Isoform: An Attractive Target for Drug Development
Subhabrata Chaudhury, Terin D’Amico, Brian S. J. Blagg
Medicinal Research Reviews (2025)
Open Access

The role of HSP90 molecular chaperones in hepatocellular carcinoma
Masoud Nouri‐Vaskeh, Leila Alizadeh, Khalil Hajiasgharzadeh, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9110-9120
Closed Access | Times Cited: 30

Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat
Nasreddine El Omari, Asaad Khalid, Hafiz A. Makeen, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33052-e33052
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top